Home / Levosimendan / Sweden
SE ATC C01CX08 · updated 2 Nov 2026
Levosimendan shortage in Sweden
Is there a Levosimendan shortage in Sweden?
Yes. As of 2 Nov 2026, 2 Levosimendan products are reported short in Sweden, the first since 29 Nov 2023. The company estimate for the return is 25 Dec 2026 (latest 31 Jan 2027). Main reason: not stated.
Also short in Italy, Spain, Czechia. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Levosimendan Kalceks 2,5 mg/ml Injektionsflaska, 1 x 5 ml | AS KALCEKS | 29 Nov 2023 | 25 Dec 2026 | Not stated |
| SE | Levosimendan EQL Pharma 2,5 mg/ml Injektionsflaska 1 x 5 ml | EQL Pharma AB | 7 Aug 2024 | 31 Jan 2027 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.